我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Does Insurance Type, Private Versus Public, Have a Correlation with MRSA Carrier Status In a Population Undergoing Orthopedic Surgery?

Jeremie M Axe, Jessie Osbourne Paull, Steven Vlad and John Richmond

Background: Preoperative nasal colonization with Staphylococcus aureus (SA) is a strong risk factor for surgical site infection (SSI). Methicillin-resistant SA (MRSA) positive carriers are at a much higher risk of SSI than MRSA negative patients. MRSA screening is expensive. Treatment of everyone with single dose antibiotic is very inexpensive, but has downstream negative consequences. This presents a conundrum. Surrogate measures for MRSA colonization may include insurance status in individuals below Medicare age. Massachusetts Health reform law mandates that Massachusetts residents obtain a state government-regulated minimum level of healthcare insurance coverage termed MassHealth. Questions/Purposes: We hypothesized that patients with government issued insurance would have higher rates of preoperative MRSA colonization compared to those who carry private insurance and that this information could be used to develop treatment algorithms for those undergoing orthopedic procedures that would cost less than screening all patients while avoiding the consequences of routine single dose antibiotic prescription for all.
Methods: We performed nasal MRSA screening on all adults undergoing elective inpatient or outpatient orthopaedic surgery at a single institution for the fiscal years 2007 through 2011. The variables of interest included insurance type, age and sex.
Results: The overall incidence of MRSA nasal colonization was 3.9%. For those under 65, the percentage of MRSA colonization in patients with government issued insurance (Medicaid and MassHealth) was more than 3 time that of those with private insurance.
Conclusion: Our observations suggest that institutions that do not institute MRSA screening programs, or in emergency situations, might consider government issued insurance, specifically Medicaid, as a risk factor for possible MRSA colonization and consider adjusting perioperative antibiotics accordingly. In many states, the Affordable Care Act will include an expansion of Medicaid to similar levels like Massachusetts, potentially making these results applicable nationwide. Level of Evidence III Cross-sectional Study

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。